Abstract | BACKGROUND: METHODS: A retrospective chart review was performed on 28 patients undergoing total hip arthroplasty or hip resurfacing who received intraoperative administration of liposomal bupivacaine. A control group of 30 patients who had previously undergone total hip arthroplasty or hip resurfacing and had received intraoperative administration of bupivacaine also underwent a chart review. Length of stay, post-operative opioid use, and pain scores were compared for both groups. RESULTS: The average length of stay in the study group was 1.93 days and the control group length of stay was 2.47 days (p ≤ 0.05). Morphine equivalent use was less in the study group during the first 24 hours compared to the control group (p ≤0.05). During the second and third 24 hours the morphine equivalent use difference was not statistically significant. Visual analogue scores were not significantly different between groups at any time point. CONCLUSION:
|
Authors | Benjamin G Domb, Asheesh Gupta, Jon E Hammarstedt, Christine E Stake, Kinzie Sharp, John M Redmond |
Journal | BMC musculoskeletal disorders
(BMC Musculoskelet Disord)
Vol. 15
Pg. 310
(Sep 24 2014)
ISSN: 1471-2474 [Electronic] England |
PMID | 25248686
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anesthetics, Local
- Liposomes
- Bupivacaine
|
Topics |
- Anesthetics, Local
(administration & dosage)
- Arthroplasty, Replacement, Hip
(methods)
- Bupivacaine
(administration & dosage)
- Cohort Studies
- Female
- Humans
- Intraoperative Care
- Length of Stay
(trends)
- Liposomes
- Male
- Middle Aged
- Pain, Postoperative
(prevention & control)
- Retrospective Studies
- Treatment Outcome
|